نتایج جستجو برای: cervarix
تعداد نتایج: 115 فیلتر نتایج به سال:
For nearly a century, aluminum salts have been the most widely used vaccine adjuvant formulation, and have thus established a history of safety and efficacy. Nevertheless, for extremely challenging disease targets such as tuberculosis or HIV, the adjuvant activity of aluminum salts may not be potent enough to achieve protective efficacy. Adsorption of TLR ligands to aluminum salts facilitates e...
Background: Cervical cancer is the 2nd most common in India. It cause of death developing countries. According to current global status 2016, age-standardized incidence rate cervical varies between 5.6 24.3 per 1 lakh women Human papillomavirus (HPV) responsible for subclinical/clinical lesions cancer. occurs early and strikes at productive period a woman’s life. The vaccines against HPV are bi...
This issue of the Journal presents the results of an experimental project describing the technology and the model system to generate novel human papillomavirus (HPV) vaccines. Rather than using the immune capacity of the L1 capsid epitopes, these prototypes are based on the unique properties of the L2 protein of the capsid to induce broad-spectrum (BS) HPV antigenic recognition and the formatio...
©FSRH J Fam Plann Reprod Health Care 2008: 34(4) Background The UK’s human papillomavirus (HPV) vaccination programme should now be underway: vaccination of 12–13year-old girls against HPV was due to begin in September 2008, with a recent announcement that 17–18-year-olds will also be vaccinated in this academic year.1 From September 2009, a further catch-up programme for girls up to the age of...
The Journal of Clinical Investigation http://www.jci.org Volume 115 Number 10 October 2005 2587 Richard Schlegel is a pioneer in human papillomavirus (HPV) research. Schlegel, chairman of the Department of Pathology at Georgetown University Medical Center, has long studied the protein shell surrounding HPV. His work led to the development of a vaccine called Cervarix, currently in clinical tria...
Since the discovery of the causal association between human papillomavirus (HPV) and cervical cancer, efforts to develop an effective prophylactic vaccine to prevent high-risk HPV infections have been at the forefront of modern medical research. HPV causes 530,000 cervical cancer cases worldwide, which is the second most common cause of cancer deaths in women; a worldwide collaboration among ep...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید